Author: Tom Patriot

Bebe Rexha on Dating in the Spotlight and Defining Her Sexuality: ‘I Consider Myself Fluid’

Tom Patriot

Big things are happening for Bebe Rexha. The 29-year-old broke out in late 2017 with “Meant to Be,” her ubiquitous hit with country duo Florida Georgia Line, which peaked at No. 2 on Billboard’s Hot 100 and topped the Hot Country Songs chart for a record-breaking 50 consecutive weeks. Within the past year she has also released her debut studio album, Expectations; was nominated for two Grammys (including Best New Artist); and became the Comeback Stage coach on The Voice. Considering all of this, it’d be easy to call Bebe an overnight sensation—but that would…

Read More

Inflamed monkey guts produce Parkinson’s-related proteins

Tom Patriot

The intestinal linings of monkeys with inflamed bowels show chemical alterations similar to abnormal protein deposits in the brains of Parkinson’s patients, lending support to the idea that inflammation may play a key role in the development of the degenerative neurological disorder. A study published by University of Wisconsin–Madison researchers today in the Journal of Inflammation Research found phosphorylated alpha-synuclein — a modified version of a protein common to nerve cells — in samples from common marmosets kept in a tissue bank at the Wisconsin National Primate Research Center. “It’s not entirely…

Read More

President Trump’s Mixed Messages on Trade Deal Rattle the Stock Market

Tom Patriot

The stock market whipsawed as the President delivered conflicting messages about ongoing trade negotiations between the U.S. and China. Yesterday, the President said that China had broken the deal but suggested that an agreement could still be reached before more tariffs on Chinese goods take effect at midnight tonight. He also added that tariffs were an “excellent” alternative to a deal. Investors don’t know what to make of the situation. Stock prices were down sharply this morning before recovering ground in the afternoon. The Dow and S&P indexes ended the…

Read More

Researchers develop prostate cancer prediction tool that has unmatched accuracy

Tom Patriot

A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California (USC) have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before. The framework, described in a Scientific Reports paper published today, is intended to help physicians — in particular, radiologists — more accurately identify treatment options for prostate cancer patients, lessening the chance of unnecessary clinical intervention. Prostate cancer is one of the leading causes of…

Read More

Some biologic treatments for psoriasis may be safer for patients

Tom Patriot

A common chronic skin condition affecting 125 million people worldwide, psoriasis is an autoimmune disease, a class of disorders in which the immune system attacks the body’s own healthy cells. In recent years, new medications — known as biologics — that inhibit the overactive immune system by targeting specific inflammatory pathways, have revolutionized the treatment of psoriasis and other autoimmune diseases. However, until now, few studies have documented the comparative safety of these various biologics. In the largest study of its kind, clinician-researchers compared the risk of serious infection —…

Read More